May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Mark Lythgoe: Do we need to re-evaluate the clinical utility of how we measure PDL1?
Apr 14, 2025, 11:06

Mark Lythgoe: Do we need to re-evaluate the clinical utility of how we measure PDL1?

Mark Lythgoe, Clinical Research Fellow in Medical Oncology at Imperial College London, shared a post on X:

“Not all PDL1 assays are the same in bladder cancer – important work. do we need to re-evaluate the clinical utility of how we measure PDL1 and does this have implications for other cancers???”

Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer 

Authors: Matthew D. Galsky et al.

Mark Lythgoe